Strategic Plan

Clinical Immunology Society Strategic Plan Summary

The Clinical Immunology Society (CIS) Executive Committee convened in 2018 to establish a five-year strategic plan. This plan extending into 2023, will provide guidance into the activities of the CIS to ensure that every action is in line with the goals and missions of the society.




During the next five years, CIS is committed to increasing the communication not only between leadership and the membership at large, but the communication strategies that extend further than the organization. The following tasks will help CIS reach this goal:

  •  Twitter Q&A sessions
  •  Regular updates to membership concerning various programs and initiatives that develop within the leadership
  • Outreach to regular meeting attendees that aren’t otherwise involved
  • Creating multiple slides for leadership/membership to use highlighting ongoing initiatives of the Society


While CIS prides itself on its existing partnerships and the founding of the International Alliance for Primary Immunodeficiency Societies (IAPIDS), the next five years will bring about the formation of several other partnerships that will further educational opportunities as well as to broaden the scope of the Society. Over the next five years, the CIS will look to partner with the following organizations:

  • International Patient Organisation for Primary Immunodeficiencies (IPOPI)
  • North American Immuno-Hematology Clinical Education and Research Consortium (NICER)
  • American Society of Pediatric Hematology/Oncology (ASPHO)
  • International Society of Systemic Autoinflammatory Diseases (ISSAID)
  • Childhood Arthritis & Rheumatology Research Alliance (CARRA)
  • Association of Medical Laboratory Immunologists (AMLI)
  • International Clinical Cytometry Society (ICCS)
  • American College of Medical Genetics and Genomics (ACMG)

Additionally, CIS will continue to work with IAPIDS, and look to develop proactive and strategic engagement to benefit the partner societies, as well as their members.



The CIS leadership appreciates the fact that its members are the cornerstone of the Society. While all of these initiatives are meant to serve the Membership, there are specific ways in which CIS is hoping to not only grow membership, but looking to provide resources specifically to benefit its members. Some of these initiatives include:

  • Hosting an exhibition booth at the American College of Allergy, Asthma, and Immunology (ACAAI) Annual Meeting
  • Co-sponsor an educational session at the American Academy of Allergy, Asthma, and Immunology (AAAAI) annual meeting
  • Registration discounts for abstract submitters
  • Provide an in-person opportunity for Mentors/Mentees to meet
  • Advertise free trainee membership at other related meetings
  • Increase number of Trainee Members
  • Explore updating price structure for Membership Dues
  • Offer 3-year membership renewal for all Regular Members beginning in 2019
  • Develop a questionnaire to provide a salary negation tool for ECI Members
  • Updating How I Became an Immunologist on the CIS website highlighting various CIS Members
  • Create a new VUS listserv


Because the work that all CIS members conduct on a daily basis is so innovative to the field at-large, the services that it offers should do the same. The leadership would like to explore the following initiatives:

  • E-Posters at the Annual Meeting
  • Audience Response sessions at the Annual Meeting
  • Continue to participate on Social Media platforms


CIS is dedicated to providing cutting-edge resources for its members to promote excellence in research and clinical care. Moving forward, the CIS would like to focus on: 

  • Sponsored Session at the AAAAI Annual Meeting
  • Sponsored Session at the ACAAI Annual Meeting
  • Provide clinical content on  the CIS Website
  • Joint Symposium with NICER at the 2020 CIS Annual Meeting
  • Immunohematology Oncology
  • Session on clinical practice
  • Offer specific webinars for nurses, and genetic counselors
  • Lessons from the ListServ


Advocacy on behalf of the patient, clinician, and researcher is an extremely important core value of CIS and the leadership would like to refocus this core value in the following ways:

  • Refocus mission of Advocacy Committee
  • Help patients gain access to treatment
  • Development of clinician position papers
  • Provide topic-specific RFA’s for researchers
  • Dedicate funding from the CIS Foundation to advocacy
  •  Create a searchable Listserv (Broker for VUS)
  • The development and promotion of FILL and Thymus Registries
  • Compose a medical letter of necessity to convey the importance of genetic testing for patients suspected of having a PIDD
  • Survey of follow-up testing for failed SCID screen
  • Pediatric reference ranges
  • Case studies in immune deficiency